Need professional-grade analysis? Visit stockanalysis.com
$468.28M
80.00
1,146
N/A
Yunkang Group Ltd (2325) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at HKD0.85, up 11.84% from the previous close.
Over the past year, 2325 has traded between a low of HKD0.69 and a high of HKD4.79. The stock has lost 71.5% over this period. It is currently 82.3% below its 52-week high.
Yunkang Group Ltd has a market capitalization of $468.28M, with a price-to-earnings ratio of 80.00.
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests; and genetic reproduction and screening tests. In addition, the company offers routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. Further, it provides diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and reagent and medical equipment procurement; healthcare technology development; and project investment services. The company provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.